2023. Exploring the potential of rivaroxaban in children with cancer: advantages over standard anticoagulants. Voprosy onkologii. 69, 3 (Jun. 2023), 399–405. DOI:https://doi.org/10.37469/0507-3758-2023-69-3-399-405.